Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
Journey Medical Corporation將參加湖街資本市場第八屆年度最佳創意增長（BIG）會議
Download as PDFSeptember 09, 2024
以 PDF 格式下載 2024 年 9 月 9 日
SCOTTSDALE, Ariz., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical" or "the Company") (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration ("FDA")-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, President and Chief Executive Officer, will attend one-on-one meetings at the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference, scheduled to take place on Thursday, September 12, 2024 in New York City.
亞利桑那州斯科茨代爾，2024年9月9日（GLOBE NEWSWIRE）——Journey Medical Corporation（「Journey Medical」 或 「公司」）（納斯達克股票代碼：DERM）是一家商業階段製藥公司，主要專注於銷售和營銷經美國食品藥品監督管理局（「FDA」）批准的用於治療皮膚病的處方藥產品，今天宣佈，總裁兼首席執行官克勞德·馬拉維官員將參加湖街資本市場第八屆年度最佳創意增長（BIG）會議的一對一會議，該會議定於將於 2024 年 9 月 12 日星期四在紐約市舉行。
About Journey Medical Corporation
Journey Medical Corporation (Nasdaq: DERM) ("Journey Medical") is a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The Company currently markets seven branded and two generic products that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology's most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical's common stock is registered under the Securities Exchange Act of 1934, as amended, and it files periodic reports with the U.S. Securities and Exchange Commission ("SEC"). For additional information about Journey Medical, visit .
關於旅程醫療公司
Journey Medical Corporation（納斯達克股票代碼：DERM）（「Journey Medical」）是一家商業階段的製藥公司，主要通過其高效的銷售和營銷模式，銷售和營銷經美國食品藥品管理局批准的用於治療皮膚病的處方藥產品。該公司目前銷售七種品牌和兩種仿製產品，這些產品有助於治療和治癒常見的皮膚病。Journey Medical團隊由行業專家組成，他們在開發和商業化皮膚科一些最成功的處方品牌方面擁有豐富的經驗。Journey Medical位於亞利桑那州斯科茨代爾，由豐澤生物技術公司（納斯達克股票代碼：FBIO）創立。Journey Medical的普通股根據經修訂的1934年證券交易法註冊，並定期向美國證券交易委員會（「SEC」）提交報告。有關 Journey Medical 的更多信息，請訪問。
Company Contact:
Jaclyn Jaffe
(781) 652-4500
ir@jmcderm.com
公司聯繫人：
Jaclyn Jaffe
(781) 652-4500
ir@jmcderm.com
Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com
媒體關係聯繫人：
託尼·普洛霍羅斯
6 度
(908) 591-2839
tplohoros@6degreespr.com
Source: Journey Medical Corporation
資料來源：旅程醫療公司
Released September 9, 2024
2024 年 9 月 9 日發佈
譯文內容由第三人軟體翻譯。
